Study finds increased mortality risk with PPI use

News Hour:

Proton-pump inhibitor use is associated with increased mortality risk, finds a study in BMJ Open. Using data from the U.S. Department of Veterans Affairs, researchers examined health records of new users and nonusers of acid suppression therapy.

The authors write: “Although our results should not deter prescription and use of PPI where medically indicated, they may be used to encourage and promote pharmacovigilance and emphasize the need to exercise judicious use of PPI and limit use and duration of therapy to instances where there is a clear medical indication and where benefit outweighs potential risk.”

During a median 6 years’ follow-up, use of PPIs was associated with increased risk for death, relative to the use of H2 blockers (adjusted hazard ratio, 1.25). The risk was also increased among patients taking PPIs, compared with those not taking acid suppression therapy, and among those taking PPIs who did not have a gastrointestinal condition that would warrant a PPI prescription.

News Hour Correspondent

This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]
No Comments

Translate this News

Join the Facebook Group

Click here to join the Facebook group of News Hour

Popular Posts

Demographic consequences of COVID 19
Why Japan took a long time to go for country lockdown?
Honor Blackman, James Bond actress dies at 94
Bangladesh seeks Chinese COVID-19 expert medical team
Jack Dorsey, Twitter CEO, to pledge $1 billion for Coronavirus relief effort
Boris Johnson’s health ‘continues to improve’

Advertisement

News of the Month

Scroll Up
%d bloggers like this: